Lv11
20 积分 2024-05-28 加入
CONVERGE-01: Dosimetry, randomized dose optimization, dose escalation, and efficacy of ac-225 rosopatamab tetraxetan in participants with PSMA-positive castration-resistant prostate cancer
5小时前
求助中
A phase 1 study of JNJ-69086420 (JNJ-6420), an actinium-225 (225Ac) -labeled antibody targeting human kallikrein 2 (hK2), for metastatic castration-resistant prostate cancer (mCRPC)
5小时前
求助中
Clinical experience with PSMA-Actinium-225 (Ac-225) radioligand therapy (RLT) in end-stage metastatic castration-resistant prostate cancer (mCRPC) patients
5小时前
求助中
First-in-human study of 225actinium mti-201 (225Ac-MTI-201) in metastatic uveal melanoma (UM)
7小时前
求助中
Equilibrium and kinetic studies on the formation of the lanthanide(III) complexes, [Ce(dota)]− and [Yb(dota)]− (H4dota = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid)
1年前
已完结
皖公网安备34019202002308
